Literature DB >> 21254858

Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease.

Ariel E Feldstein, Shannon M Bailey.   

Abstract

Fatty liver disease (FLD), associated with chronic alcohol consumption or obesity, is a serious medical problem. Strong evidence indicates that oxidative stress and dysregulation of redox-sensitive signaling pathways are central to the pathobiology of FLD. Herein, this Forum summarizes current knowledge regarding mechanisms of FLD from both clinical and experimental studies. Special emphasis is given to the role of redox biology disturbances in the initiation and progression of FLD from both chronic alcohol consumption and obesity. Focus areas in this Forum include discussions on the (i) multi-hit hypothesis; (ii) interaction of adipokines and redox signaling pathways; (iii) role of sub-cellular organelle systems (i.e., endoplasmic reticulum and mitochondria); and (iv) contribution of the innate immune system, in FLD. A state-of-the-art discussion is also included highlighting key lessons learned from experimental studies using rodent models of FLD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254858      PMCID: PMC3118602          DOI: 10.1089/ars.2011.3897

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  25 in total

Review 1.  Epidemiology of nonalcoholic fatty liver.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Clin Liver Dis       Date:  2004-08       Impact factor: 6.126

Review 2.  Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Melinda Frye; Michael J Pagliassotti
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

3.  Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.

Authors:  Jorge A Marrero; Robert J Fontana; Sherry Fu; Hari S Conjeevaram; Grace L Su; Anna S Lok
Journal:  J Hepatol       Date:  2005-02       Impact factor: 25.083

Review 4.  Adipokines and redox signaling: impact on fatty liver disease.

Authors:  Maurizio Parola; Fabio Marra
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

5.  Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice.

Authors:  Xiaomei Liang; Ming Hu; Christopher Q Rogers; Zheng Shen; Min You
Journal:  Antioxid Redox Signal       Date:  2011-05-04       Impact factor: 8.401

6.  Transcriptional profile of genes involved in oxidative stress and antioxidant defense in a dietary murine model of steatohepatitis.

Authors:  Agnieszka Gornicka; Gareth Morris-Stiff; Samjhana Thapaliya; Bettina G Papouchado; Michael Berk; Ariel E Feldstein
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 7.  Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease.

Authors:  C P Day
Journal:  Liver Int       Date:  2006-11       Impact factor: 5.828

8.  Deaths: preliminary data for 2004.

Authors:  Arialdi M Miniño; Melonie P Heron; Betty L Smith
Journal:  Natl Vital Stat Rep       Date:  2006-06-28

Review 9.  Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

Authors:  Brent A Neuschwander-Tetri; Stephen H Caldwell
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

10.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

View more
  26 in total

1.  Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.

Authors:  Ming Tong; Lisa Longato; Teresa Ramirez; Valerie Zabala; Jack R Wands; Suzanne M de la Monte
Journal:  Int J Exp Pathol       Date:  2013-10-29       Impact factor: 1.925

2.  Mitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in mice.

Authors:  Angela M Betancourt; Adrienne L King; Jessica L Fetterman; Telisha Millender-Swain; Rachel D Finley; Claudia R Oliva; David R Crowe; Scott W Ballinger; Shannon M Bailey
Journal:  Biochem J       Date:  2014-07-15       Impact factor: 3.857

3.  NADPH Oxidases in Chronic Liver Diseases.

Authors:  Joy X Jiang; Natalie J Török
Journal:  Adv Hepatol       Date:  2014-11-30

4.  Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin.

Authors:  Xuan Zou; Chunhong Yan; Yujie Shi; Ke Cao; Jie Xu; Xun Wang; Cong Chen; Cheng Luo; Yuan Li; Jing Gao; Wentao Pang; Jialong Zhao; Fei Zhao; Hao Li; Adi Zheng; Wenyan Sun; Jiangang Long; Ignatius Man-Yau Szeto; Youyou Zhao; Zhizhong Dong; Peifang Zhang; Junkuan Wang; Wuyuan Lu; Yong Zhang; Jiankang Liu; Zhihui Feng
Journal:  Antioxid Redox Signal       Date:  2014-02-18       Impact factor: 8.401

5.  Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis.

Authors:  Teresa Ramirez; Lisa Longato; Miroslav Dostalek; Ming Tong; Jack R Wands; Suzanne M de la Monte
Journal:  Alcohol Alcohol       Date:  2012-09-20       Impact factor: 2.826

Review 6.  Alcohol abuse: critical pathophysiological processes and contribution to disease burden.

Authors:  Patricia E Molina; Jason D Gardner; Flavia M Souza-Smith; Annie M Whitaker
Journal:  Physiology (Bethesda)       Date:  2014-05

7.  Aggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in rats.

Authors:  André F Nascimento; Blanche C Ip; Renata A M Luvizotto; Helmut K Seitz; Xiang-Dong Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

Review 8.  Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.

Authors:  Megan J Reiniers; Rowan F van Golen; Thomas M van Gulik; Michal Heger
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

9.  Elevated autophagic sequestration of mitochondria and lipid droplets in steatotic hepatocytes of chronic ethanol-treated rats: an immunohistochemical and electron microscopic study.

Authors:  Nabil Eid; Yuko Ito; Kentaro Maemura; Yoshinori Otsuki
Journal:  J Mol Histol       Date:  2013-02-01       Impact factor: 2.611

10.  Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver.

Authors:  Rebecca L Smathers; James J Galligan; Colin T Shearn; Kristofer S Fritz; Kelly Mercer; Martin Ronis; David J Orlicky; Nicholas O Davidson; Dennis R Petersen
Journal:  J Lipid Res       Date:  2013-01-28       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.